Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience

BackgroundDonor-specific anti-HLA antibodies (DSA) impact negatively on the outcome of intestinal grafts. Although the use of antibody-removal therapies (ART) is becoming more frequent in the last few years, issues regarding their timing and effectiveness remain under discussion.MethodsIn the presen...

Descripció completa

Dades bibliogràfiques

Autors principals:	María Lasa-Lázaro, Esther Ramos-Boluda, Esther Mancebo, María José Castro-Panete, Rocío González-Sacristán, Javier Serradilla, Ane Miren Andrés-Moreno, Francisco Hernández-Oliveros, Estela Paz-Artal, Paloma Talayero
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-02-01
Col·lecció:	Frontiers in Pediatrics
Matèries:	intestinal transplantation multivisceral transplantation donor-specific antibodies antibody-removal therapies pediatric transplantation
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fped.2022.1074577/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!